Enterostatin (vpdpr) and its peptide fragment dpr reduce serum cholesterol levels after oral administration in mice

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 7, 2003, Pages 1620-1622

  Takenaka, Yasuyuki ^a,b   Nakamura, Futoshi ^a,c   Yamamoto, Taichi ^a,d   Yoshikawa, Masaaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kobe Shoin Women's University   (Japan)

^c CALPIS Co Ltd   (Japan)

^d KIKKOMAN CORPORATION   (Japan)

Author keywords

Bile acids; Enterostatin; Hypocholesterolemic effect

Indexed keywords

CHOLESTEROL; OLIGOPEPTIDE; PEPTIDE FRAGMENT; VALYL PROLYL ASPARTYL PROLYL ARGININE; VALYL-PROLYL-ASPARTYL-PROLYL-ARGININE;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DRUG EFFECT; FAT INTAKE; FECES; LIVER; MOUSE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; CHOLESTEROL; DIETARY FATS; FECES; LIVER; MICE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS;

EID: 2442486652     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.67.1620     Document Type: Article

References (17)

1. Erlanson-Albertsson, C., Pancreatic colipase. Structure and physiological aspects. Biochim. Biophys. Acta, 1125, 1-7 (1992).
2. Erlanson-Albertsson, C., and Larsson, A., The activation peptide of pancreatic procolipase decreases food intake in rats. Regul. Pept., 22, 325-331 (1988).
3. Lin, L., Chen, J., and York, D. A., Chronic ICV enterostatin preferentially reduced fat intake and lowered body weight. Peptides, 18, 657-661 (1997).
4. Lin, L., Okada, S., York, D. A., and Bray, G. A., Structural requirements for the biological activity of enterostatin. Peptides, 15, 849-854 (1994).
5. Lin, L., and York, D. A., Enterostatin actions in the amygdala and PVN to suppress feeding in the rat. Peptides, 18, 1341-1347 (1997).
6. Mei, J., and Erlanson-Albertsson, C., Role of intrad-uodenally administered enterostatin in rats; inhibition of food. Obesity Res., 4, 161-165 (1996).
7. Okada, S., Lin, L., York, D. A., and Bray, G. A., Chronic effects of intracerebral ventricular enterostatin in Osborne-Mendel rats fed a high-fat diet. Physiol. Behav., 54, 325-329 (1993).
8. Shargill, N. S., Tsujii, S., Bray, G. A., and Erlanson-Albertsson, C., Enterostatin suppresses food intake following injection into the third ventricle of rats. Brain Res., 544, 137-140 (1991).
9. Nagase, H., Bray, G. A., and York, D. A., Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res., 709, 44-50 (1997).
10. Lin, L., Umahara, M., York, D. A., and Bray, G. A., b-Casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides, 19, 325-331 (1998).
11. Bryant, H. U., Story, J. A., and Yim, G. K., Morphine-induced alterations in plasma and tissue cholesterol levels. Life Sci., 41, 545-554 (1987).
12. Takenaka, Y., Nakamura, F., Jinsmaa, Y., Lipkowski, A. W., and Yoshikawa, M., Enterostatin (VPDPR) has anti-analgesic and anti-amnesic activities. Biosci. Biotechnol. Biochem., 65, 236-238 (2001).
13. Mei, J., Bouras, M., and Erlanson-Albertsson, C., Inhibition of insulin release by intraduodenally infused enterostatin-VPDPR in rats. Peptides, 18, 651-655 (1997).
14. Folch, J., Lees, M., and Sloane-Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509 (1957).
15. Sugano, M., Yamada, Y., Yoshida, K., Hashimoto, Y., Matsuo, T., and Kimoto, M., The hypocholesterolemic action of the undigested fraction of soybean protein in rats. Atherosclerosis, 72, 115-122 (1988).
16. Nagaoka, S., Futamura, Y., Miwa, K., Awano, T., Yamauchi, K., Kanamaru, Y., Tadashi, K., and Kuwata, T., Identification of novel hypocholestero-lemic peptides derived from bovine milk b-lac-toglobulin. Biochem. Biophys. Res. Commun., 281, 11-17 (2001).
17. Takenaka, Y., Nakamura, F., Usui, H., Lipkowski, A. W., Toth, G., and Yoshikawa, M., Anti-analgesic activity of enterostatin (VPDPR) is mediated by corticosterone. Peptides, in press.